Expertise in
7
conditions

Dr. Christina Henson

Oncology
Ou Health Stephenson Cancer Center-Radiation Therapy
800 NE 10th St # L100, 
Oklahoma City, OK 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
7
conditions
Ou Health Stephenson Cancer Center-Radiation Therapy
800 NE 10th St # L100, 
Oklahoma City, OK 

Overview

Christina Henson is an Oncologist practicing medicine in Oklahoma City, Oklahoma.

Dr. Henson is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Breast Cancer, and Squamous Cell Skin Carcinoma.

She is actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 11 clinical trials.

Specialties

Oncology

Licenses

Internal Medicine in OK

Hospital Affiliations

Oklahoma Heart Hospital, LLC
O U Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Ou Health Stephenson Cancer Center-Radiation Therapy
800 NE 10th St # L100, Oklahoma City, OK 73104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer
A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer
Enrollment Status: Recruiting
Publish Date: April 15, 2026
Intervention Type: Drug, Other
Study Phase: Phase 3
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Enrollment Status: Recruiting
Publish Date: March 23, 2026
Intervention Type: Drug, Other, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 3
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Randomized Phase II/III Trial of Radiation With Cisplatin at 100 mg/m2 Every Three Weeks Versus Radiation With Weekly Cisplatin at 40 mg/m2 for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Enrollment Status: Suspended
Publish Date: April 03, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2/Phase 3
Phase III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck
Phase III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: February 24, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
A Single-arm Phase II Trial of Palliative QUAD SHOT Radiotherapy Combined With Pembrolizumab in Patients With Recurrent Head & Neck Cancer
A Single-arm Phase II Trial of Palliative QUAD SHOT Radiotherapy Combined With Pembrolizumab in Patients With Recurrent Head & Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 24, 2025
Intervention Type: Drug
Study Phase: Phase 2
Phase I Trial of BAY 1895344 ATR Inhibitor Combined With Stereotactic Body Radiation Therapy and Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma
Phase I Trial of BAY 1895344 ATR Inhibitor Combined With Stereotactic Body Radiation Therapy and Pembrolizumab for Recurrent Head and Neck Squamous Cell Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: December 13, 2024
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Elimusertib, Pembrolizumab
Study Phase: Phase 1
View 8 Less Clinical Trials

42 Total Publications

Beneath the surface: When a locally aggressive squamous cell carcinoma is revealed to be a squamoid eccrine ductal carcinoma.
Beneath the surface: When a locally aggressive squamous cell carcinoma is revealed to be a squamoid eccrine ductal carcinoma.
Journal: JAAD case reports
Published: October 13, 2025
Similar Doctors
Expertise in
10
conditions
Dr. James George
Hematology | Oncology
Expertise in
10
conditions
Dr. James George
Hematology | Oncology

South Wellness Community Health Clinic

1122 NE 13th St, 
Oklahoma City, OK 
 (0.5 miles away)
405-271-8299
Languages Spoken:
English
See accepted insurances

James George is a Hematologist and an Oncologist practicing medicine in Oklahoma City, Oklahoma. Dr. George is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Blood Clots, Immune Thrombocytopenic Purpura (ITP), Hemolytic-Uremic Syndrome, and Splenectomy.

Expertise in
20
conditions
Dr. Joan Walker
Oncology
Expertise in
20
conditions
Dr. Joan Walker
Oncology

Ou Health Stephenson Cancer Center-Gynecologic Cancer Clinic

800 NE 10th St Ste 2100, 
Oklahoma City, OK 
 (0.4 miles away)
405-271-8707
Experience:
44+ years
Languages Spoken:
English
See accepted insurances

Joan Walker is an Oncologist practicing medicine in Oklahoma City, Oklahoma. She has been practicing medicine for over 44 years. Dr. Walker is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Sertoli-Leydig Cell Tumor, Gamma Knife Radiosurgery, and Ureteroscopy.

Expertise in
57
conditions
Dr. Aleda Toma
Oncology
Expertise in
57
conditions
Dr. Aleda Toma
Oncology

SSM Health Cancer Care

3525 N.W. 56th St., Suite 100D, 
Oklahoma City, OK 
 (5.8 miles away)
405-942-9200
Languages Spoken:
English
See accepted insurances

Board certified in both medical oncology and internal medicine, Aleda Toma, MD is a member of Cancer Specialists of Oklahoma, a part of SSM Health St. Anthony. She cares for patients in north Oklahoma City and surrounding areas, as well as Shawnee, Okla. Dr. Toma is highly rated in 57 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Colorectal Cancer, and Familial Colorectal Cancer. Dr. Toma is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine/Medical Oncology , Drug Enforcement Administration , Oklahoma Bureau Of Narcotics And Dangerous Drugs , and Oklahoma State Board Of Medical Licensure & Supervision.

Frequently Asked Questions about Dr. Christina Henson

How do I make an appointment with Dr. Christina Henson?

You can book an appointment with Dr. Christina Henson by calling their office at 405-271-5641. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Christina Henson a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christina Henson is classified as an Distinguished expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Christina Henson specialize in?

While Dr. Christina Henson is a Oncology, they have specific expertise in Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, and Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Christina Henson participate in research or clinical trials?

Yes. Dr. Christina Henson has published 42 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Dr. Christina Henson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Christina Henson accept my insurance?

Dr. Christina Henson accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 405-271-5641 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Henson's expertise for a condition
ConditionClose
    View All 42 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile